Eris Lifesciences Ltd
NSE:ERIS

Watchlist Manager
Eris Lifesciences Ltd Logo
Eris Lifesciences Ltd
NSE:ERIS
Watchlist
Price: 1 374.2 INR 0.53% Market Closed
Market Cap: 187B INR
Have any thoughts about
Eris Lifesciences Ltd?
Write Note

Eris Lifesciences Ltd
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eris Lifesciences Ltd
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Eris Lifesciences Ltd
NSE:ERIS
Common Shares Outstanding
â‚ą136m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Common Shares Outstanding
â‚ą832.6m
CAGR 3-Years
71%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Common Shares Outstanding
â‚ą807.6m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Common Shares Outstanding
â‚ą2.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Common Shares Outstanding
â‚ą338.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
M
Mankind Pharma Ltd
NSE:MANKIND
Common Shares Outstanding
â‚ą400.6m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Eris Lifesciences Ltd
Glance View

Market Cap
186.9B INR
Industry
Pharmaceuticals

Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-06-29. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals and nutrients (VMN). The firm's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited and Eris Healthcare Private Limited.

ERIS Intrinsic Value
1 082.77 INR
Overvaluation 21%
Intrinsic Value
Price

See Also

What is Eris Lifesciences Ltd's Common Shares Outstanding?
Common Shares Outstanding
136m INR

Based on the financial report for Jun 30, 2024, Eris Lifesciences Ltd's Common Shares Outstanding amounts to 136m INR.

What is Eris Lifesciences Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
0%

Over the last year, the Common Shares Outstanding growth was 0%.

Back to Top